Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PARK7 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Invitae Hereditary Parkinson Disease and Parkinsonism Panel Invitae United States | 44 | 26 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Parkinson Disease and Parkinsonism Panel PreventionGenetics, part of Exact Sciences United States | 68 | 70 |
|
PreventionGenetics, part of Exact Sciences United States | 27 | 24 |
|
Parkinson's Disease, Early Onset via the PARK7 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Baylor Genetics United States | 842 | 637 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Parkinson deletion/duplication analysis Duzen Laboratories Duzen BBAGUAS Turkey | 8 | 8 |
|
Amyotrophic Lateral Sclerosis (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 25 | 30 |
|
Parkinson Disease , Deletions-Duplications (MLPA) SNCA, PARK2, PINK1, PARK7, LRRK2, UCHL1 Genes Reference Laboratory Genetics Spain | 6 | 6 |
|
PARK7 Gene Sequencing and Deletion/Duplication Analysis DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children United States | 1 | 1 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 27 | 28 |
|
PARK7 (DJ1) - Gene Sequencing & Del/Dup analysis Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 2 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Complete Parkinsonism Evaluation Athena Diagnostics United States | 6 | 5 |
|
Athena Diagnostics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.